EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis

Miyesaier Abudureyimu, Guizhen Wang, Xing Qin, Peizhi Miao, Jie Qi, Richard Bucala, Rong Chen, Junbo Ge, Yingmei Zhang, Xuanming Luo, Jun Ren

Acta Pharmaceutica Sinica B · 2026-05 · 16 (5) · 2982-3000

DOI: 10.1016/j.apsb.2026.01.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Miyesaier Abudureyimu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Shanghai Xuhui Central Hospital, Fudan University, Shanghai 200031, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX)-induced cardiotoxicity (DIC) is a major health threat that limits its clinical application. While mitochondrial dysfunction, oxidative stress and ferroptosis are implicated in DIC pathology, the precise mechanism remains elusive. This study evaluated the role of cluster of differentiation 74 (CD74), an immunoregulatory protein, in DIC. Our findings revealed elevated CD74 levels in blood samples from DOX-exposed patients and DOX-challenged mouse hearts. CD74 deletion mitigated DOX-indued cardiac remodeling, contractile anomaly, mitochondrial abnormalities, apoptosis, and ferroptosis. Mechanistically, CD74 bound to DNA synthesis molecule ribonucleotide reductase M2 (RRM2), redistributing it from cytoplasm to plasma membrane, impairing DOX-induced repair and exacerbating mitochondrial injury, apoptosis, and ferroptosis via activation of RRM2/p53 cascade. Notably, a CD74 mutant (aa 220-250) failed to aggravate DOX-induced cardiac dysfunction, unlike WT CD74. Moreover, the protective effects of CD74 inhibition in cardiomyocytes were negated by p53 activation, highlighting its role in DOX-induced damage. Treatment with CD74 inhibitor Amifostine in a DIC mouse model significantly alleviated cardiac remodeling and functional impairment by reducing oxidative stress and ferroptosis. Transwell study using the CD74-null Raw 264.7 macrophages and cardiomyocytes revealed that CD74 knockdown in macrophages overly attenuated DOX-instigated cardiomyocyte dysfunction. These findings establish CD74 as a potential therapeutic target for DIC, as its regulation of RRM2 cytomembrane diversion and ferroptosis ultimately drives cardiac remodeling and contractile anomalies in response to DOX challenge.

Schlagwörter

Stichwörter der Autor:innen

AmifostineCD74CardiotoxicityDoxorubicinFerroptosisMitochondrial integrityOxidative stress

Autor:innen und Institutionen

  • Cardiovascular Department, Shanghai Xuhui Central Hospital, Fudan University, Shanghai 200031, China.
  • Department of Emergency, Shanghai Tenth People's Hospital, School of Medicine Tongji University, Shanghai 200072, China.
  • Department of Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, China.
  • Department of Cardiology, Xijing Hospital, Air Force Medical University, Xi'an 710032, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.
  • Department of Medicine, Yale School of Medicine, New Haven, CT 06520, USA.

Förderung

  • National Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars
  • Chinese Academy of Sciences

Zitieren

APA

Abudureyimu, M., Wang, G., Qin, X., Miao, P., Qi, J., Bucala, R., Chen, R., Ge, J., Zhang, Y., Luo, X., & Ren, J. (2026). CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis. Acta Pharmaceutica Sinica B, 16(5), 2982-3000. https://doi.org/10.1016/j.apsb.2026.01.028

Vancouver

Abudureyimu M, Wang G, Qin X, Miao P, Qi J, Bucala R, et al. CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis. Acta Pharmaceutica Sinica B. 2026;16(5):2982-3000. doi:10.1016/j.apsb.2026.01.028

BibTeX
@article{Abudureyimu2026,
  author = {Abudureyimu, Miyesaier and Wang, Guizhen and Qin, Xing and Miao, Peizhi and Qi, Jie and Bucala, Richard and Chen, Rong and Ge, Junbo and Zhang, Yingmei and Luo, Xuanming and Ren, Jun},
  title = {CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {2982--3000},
  doi = {10.1016/j.apsb.2026.01.028}
}
Kostenlos starten →